Insiders

03-26 Geron Corporation Announces the Appointment of Patricia S. Andrews and Constantine Chinoporos to Board of Directors CI
03-12 Ipsen appoints Michelle C. Werner as Head of North America Zonebourse
03-12 Ipsen Announces Executive Changes CI
02-24 Tectonic Therapeutic, Inc. Announces Board and Committees Changes CI
02-04 Pyxis Oncology, Inc. Announces Chief Executive Officer Changes, Effective February 3, 2026 CI
02-03 Ipsen Sa Appoints Pierrick Lefranc as Executive Vice President and Member of the Executive Leadership Team, Effective April 1, 2026 CI
01-29 Ipsen Nominates Peter Guenter to its Board of Directors, Effective January 28, 2026 CI
01-29 Peter Guenter Appointed to Ipsen's Board of Directors Zonebourse
01-27 Ipsen Announces Executive Changes CI
12-01 Ipsen Announces Demise of Board Member Henri Beaufour on November 28, 2025 CI
23/07/25 Ipsen S.A. Announces New Appointments to Its Executive Committee CI
06/05/25 Ipsen Appoints Laura Réveillon as Evp, Strategy & Transformation Effective May 14, 2025 CI
04/03/25 Oncodesign Precision Medicine Appoints Christophe Thurieau as Member of the Board of Directors CI
30/01/25 Former exec at drugmaker Ipsen sentenced to prison for insider trading RE
09/12/24 Nuvalent, Inc. Appoints Grant Bogle to Board of Directors CI
02/10/24 Quanterix Corporation Appoints Ivana Magovcevic-Liebisch as Class III Director and as A Member of the Compensation Committee CI
10/09/24 Employee of French drugmaker Ipsen to plead guilty to US insider trading RE
05/09/24 Nanobiotix: two appointments to the Supervisory Board Zonebourse
16/08/24 Genmab A/S Announces Executive Changes CI
06/06/24 Ipsen Hires New Chief Corporate Affairs Officer MT
06/06/24 Ipsen: new Chief Corporate Affairs Officer Zonebourse
02/05/24 Ipsen Announces Executive Changes CI
02/05/24 Ipsen: new President for North America Zonebourse
04/09/23 Ipsen: appointment of an independent director Zonebourse
01/09/23 Ipsen appoints new R&D Director Zonebourse
No results for this search